Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

January 2005

Correspondence regarding, "The Cost Effectiveness of Levalbuterol Versus Racemic Albuterol"

ByAlan L. Weiner, MD,Author reply by Campion Quinn, MD

January 15th 2005

Moving Towards Better Formulary Management

ByDana P. Goldman, PhD,Geoffrey F. Joyce, PhD

January 15th 2005

Clinical and Financial Outcomes Associated With a Proton Pump Inhibitor Prior-Authorization Program in a Medicaid Population

ByThomas Delate, PhD,Douglas E. Mager, BS,Jagat Sheth, PhD,Brenda R. Motheral, PhD

January 15th 2005

Variations of Physician Group Profiling Indicators for Asthma Care

ByI-Chan Huang, PhD,Gregory B. Diette, MD, MHS,Francesca Dominici, PhD,Constantine Frangakis, PhD,Albert W. Wu, MD, MPH

January 15th 2005

Do the Incentives in 3-Tier Pharmaceutical Benefit Plans Operate as Intended? Results From a Physician Leadership Survey

ByWilliam H. Shrank, MD, MSHS,Henry N. Young, PhD,Susan L. Ettner, PhD,Peter Glassman, MBBS, MSc,Steven M. Asch, MD, MPH,Richard L. Kravitz

January 15th 2005

Spillover Effects of Restrictive Drug Formularies: A Case Study of PacifiCare in California

ByY. Richard Wang, MD, PhD,Mark V. Pauly, PhD

January 15th 2005

Health Plan Members' Views on Forgiving Medical Errors

ByKathleen M. Mazor, EdD,Steven R. Simon, MD,Robert A. Yood, MD,Brian C. Martinson, PhD,Margaret J. Gunter, PhD,George W. Reed, PhD,Jerry H. Gurwitz, MD

January 15th 2005

Trending on AJMC

Hybrid, Outpatient, Network-Based: Bispecific Programs Take Shape Differently

Chemo-Free Options Abound for Transplant-Ineligible MCL, Kumar Explains

Study Finds Flaw in Method for Key Oncology Value-Based Care Model

Aficamten Outperforms Metoprolol Across All Phases of Exercise in Obstructive HCM

5 Ongoing Clinical Trials in Myeloproliferative Neoplasms